{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:56:01Z","timestamp":1787320561167,"version":"build-2736575974"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Eat Disord"],"DOI":"10.1186\/s40337-025-01313-y","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T09:30:41Z","timestamp":1749547841000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Reconnecting through dissociation: a 5-month follow-up case study on ketamine-assisted psychotherapy for anorexia nervosa"],"prefix":"10.1186","volume":"13","author":[{"given":"Camilla Lindvall","family":"Dahlgren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Tverrli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lowan Han","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"1313_CR1","doi-asserted-by":"publisher","first-page":"663","DOI":"10.3389\/fpsyg.2019.00663","volume":"10","author":"CL Dahlgren","year":"2019","unstructured":"Dahlgren CL, Hage TW, Wonderlich JA, Stedal K. General and eating disorder specific flexibility: development and validation of the eating disorder flexibility index (EDFLIX) questionnaire. Front Psychol. 2019;10:663.","journal-title":"Front Psychol"},{"issue":"6","key":"1313_CR2","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1097\/YCO.0000000000000545","volume":"32","author":"C Rijkers","year":"2019","unstructured":"Rijkers C, Schoorl M, Van Hoeken D, Hoek HW. Eating disorders and posttraumatic stress disorder. Curr Opin Psychiatry. 2019;32(6):510\u20137.","journal-title":"Curr Opin Psychiatry"},{"issue":"10","key":"1313_CR3","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.jaac.2010.05.017","volume":"49","author":"KR Merikangas","year":"2010","unstructured":"Merikangas KR, He J, ping, Burstein M, Swanson SA, Avenevoli S, Cui L, et al. Lifetime prevalence of mental disorders in U.S. Adolescents: results from the National comorbidity survey Replication\u2013Adolescent supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2010;49(10):980\u20139.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"1313_CR4","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s40337-022-00654-2","volume":"10","author":"A Hambleton","year":"2022","unstructured":"Hambleton A, Pepin G, Le A, Maloney D, National Eating Disorder Research Consortium, Aouad P, et al. Psychiatric and medical comorbidities of eating disorders: findings from a rapid review of the literature. J Eat Disord. 2022;10(1):132.","journal-title":"J Eat Disord"},{"issue":"12","key":"1313_CR5","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.3390\/jcm10122555","volume":"10","author":"L Puckett","year":"2021","unstructured":"Puckett L, Grayeb D, Khatri V, Cass K, Mehler P. A comprehensive review of complications and new findings associated with anorexia nervosa. J Clin Med. 2021;10(12):2555.","journal-title":"J Clin Med"},{"issue":"1","key":"1313_CR6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s40337-022-00716-5","volume":"10","author":"P Westmoreland","year":"2022","unstructured":"Westmoreland P, Duffy A, Rienecke R, Le Grange D, Joiner T, Manwaring J, et al. Causes of death in patients with a history of severe anorexia nervosa. J Eat Disord. 2022;10(1):200.","journal-title":"J Eat Disord"},{"issue":"7","key":"1313_CR7","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s11920-024-01509-0","volume":"26","author":"G Waller","year":"2024","unstructured":"Waller G, Beard J. Recent advances in Cognitive-Behavioural therapy for eating disorders (CBT-ED). Curr Psychiatry Rep. 2024;26(7):351\u20138.","journal-title":"Curr Psychiatry Rep"},{"issue":"7","key":"1313_CR8","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s11920-022-01340-5","volume":"24","author":"AF Muratore","year":"2022","unstructured":"Muratore AF, Attia E. Psychopharmacologic management of eating disorders. Curr Psychiatry Rep. 2022;24(7):345\u201351.","journal-title":"Curr Psychiatry Rep"},{"issue":"6","key":"1313_CR9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/YCO.0b013e328365a24f","volume":"26","author":"FRE Smink","year":"2013","unstructured":"Smink FRE, Van Hoeken D, Hoek HW. Epidemiology, course, and outcome of eating disorders. Curr Opin Psychiatry. 2013;26(6):543\u20138.","journal-title":"Curr Opin Psychiatry"},{"issue":"1","key":"1313_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/wps.21182","volume":"23","author":"M Solmi","year":"2024","unstructured":"Solmi M, Monaco F, H\u00f8jlund M, Monteleone AM, Trott M, Firth J, et al. Outcomes in people with eating disorders: a transdiagnostic and disorder-specific systematic review, meta\u2010analysis and multivariable meta\u2010regression analysis. World Psychiatry. 2024;23(1):124\u201338.","journal-title":"World Psychiatry"},{"issue":"1","key":"1313_CR11","first-page":"22","volume":"21","author":"TM Almeida","year":"2024","unstructured":"Almeida TM, Lacerda da Silva UR, Pereira Pires J, Neri Borges I, Muniz Martins CR, Cordeiro Q, et al. Effectiveness of ketamine for the treatment of post-traumatic stress disorder - a systematic review and meta-analysis. Clin Neuropsychiatry. 2024;21(1):22\u201331.","journal-title":"Clin Neuropsychiatry"},{"key":"1313_CR12","doi-asserted-by":"publisher","first-page":"102127","DOI":"10.1016\/j.eclinm.2023.102127","volume":"62","author":"S Nikolin","year":"2023","unstructured":"Nikolin S, Rodgers A, Schwaab A, Bahji A, Zarate C, Vazquez G, et al. Ketamine for the treatment of major depression: a systematic review and meta-analysis. eClinicalMedicine. 2023;62:102127.","journal-title":"eClinicalMedicine"},{"key":"1313_CR13","doi-asserted-by":"publisher","unstructured":"Bruton AM, Wesemann DG, Machingo TA, Majak G, Johnstone JM, Marshall RD. Ketamine for mood disorders, anxiety, and suicidality in children and adolescents: a systematic review. Eur Child Adolesc Psychiatry [Internet]. 2024 May 16 [cited 2025 Jan 9]; Available from: https:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s00787-024-02458-y","DOI":"10.1007\/s00787-024-02458-y"},{"issue":"11","key":"1313_CR14","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.biopsych.2021.03.014","volume":"89","author":"H Wu","year":"2021","unstructured":"Wu H, Savalia NK, Kwan AC. Ketamine for a boost of neural plasticity: how, but also when?? Biol Psychiatry. 2021;89(11):1030\u20132.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"1313_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41386-023-01632-1","volume":"49","author":"JN Johnston","year":"2024","unstructured":"Johnston JN, Kadriu B, Kraus C, Henter ID, Zarate CA. Ketamine in neuropsychiatric disorders: an update. Neuropsychopharmacology. 2024;49(1):23\u201340.","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"1313_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/02791072.2019.1587556","volume":"51","author":"J Dore","year":"2019","unstructured":"Dore J, Turnipseed B, Dwyer S, Turnipseed A, Andries J, Ascani G, et al. Ketamine-assisted psychotherapy (KAP): patient demographics, clinical data and outcomes in three large practices administering ketamine with psychotherapy. J Psychoact Drugs. 2019;51(2):189\u201398.","journal-title":"J Psychoact Drugs"},{"key":"1313_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.euroneuro.2023.05.008","volume":"75","author":"A Calder","year":"2023","unstructured":"Calder A, Mock S, Friedli N, Pasi P, Hasler G. Psychedelics in the treatment of eating disorders: rationale and potential mechanisms. Eur Neuropsychopharmacol. 2023;75:1\u201314.","journal-title":"Eur Neuropsychopharmacol"},{"key":"1313_CR18","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.2147\/JPR.S360733","volume":"15","author":"SJ Drozdz","year":"2022","unstructured":"Drozdz SJ, Goel A, McGarr MW, Katz J, Ritvo P, Mattina G, et al. Ketamine assisted psychotherapy: A systematic narrative review of the literature. J Pain Res. 2022;15:1691\u2013706.","journal-title":"J Pain Res"},{"issue":"11","key":"1313_CR19","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.3390\/nu13114158","volume":"13","author":"JL Keeler","year":"2021","unstructured":"Keeler JL, Treasure J, Juruena MF, Kan C, Himmerich H. Ketamine as a treatment for anorexia nervosa: A narrative review. Nutrients. 2021;13(11):4158.","journal-title":"Nutrients"},{"key":"1313_CR20","doi-asserted-by":"publisher","first-page":"764112","DOI":"10.3389\/fpsyt.2021.764112","volume":"12","author":"A Ragnhildstveit","year":"2021","unstructured":"Ragnhildstveit A, Jackson LK, Cunningham S, Good L, Tanner Q, Roughan M, et al. Case report: unexpected remission from extreme and enduring bulimia nervosa with repeated ketamine assisted psychotherapy. Front Psychiatry. 2021;12:764112.","journal-title":"Front Psychiatry"},{"issue":"5","key":"1313_CR21","doi-asserted-by":"publisher","first-page":"e03869","DOI":"10.1002\/ccr3.3869","volume":"9","author":"T Schwartz","year":"2021","unstructured":"Schwartz T, Trunko ME, Feifel D, Lopez E, Peterson D, Frank GKW, et al. A longitudinal case series of IM ketamine for patients with severe and enduring eating disorders and comorbid treatment-resistant depression. Clin Case Rep. 2021;9(5):e03869.","journal-title":"Clin Case Rep"},{"key":"1313_CR22","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3389\/fpsyt.2020.00763","volume":"11","author":"B Scolnick","year":"2020","unstructured":"Scolnick B, Zupec-Kania B, Calabrese L, Aoki C, Hildebrandt T. Remission from chronic anorexia nervosa with ketogenic diet and ketamine: case report. Front Psychiatry. 2020;11:763.","journal-title":"Front Psychiatry"},{"key":"1313_CR23","doi-asserted-by":"publisher","first-page":"1181447","DOI":"10.3389\/fpsyt.2023.1181447","volume":"14","author":"JL Keeler","year":"2023","unstructured":"Keeler JL, Treasure J, Himmerich H, Brendle M, Moore C, Robison R. Case report: intramuscular ketamine or intranasal Esketamine as a treatment in four patients with major depressive disorder and comorbid anorexia nervosa. Front Psychiatry. 2023;14:1181447.","journal-title":"Front Psychiatry"},{"issue":"1","key":"1313_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s40337-022-00588-9","volume":"10","author":"R Robison","year":"2022","unstructured":"Robison R, Lafrance A, Brendle M, Smith M, Moore C, Ahuja S, et al. A case series of group-based ketamine-assisted psychotherapy for patients in residential treatment for eating disorders with comorbid depression and anxiety disorders. J Eat Disord. 2022;10(1):65.","journal-title":"J Eat Disord"},{"issue":"1","key":"1313_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s40337-024-01039-3","volume":"12","author":"A Timek","year":"2024","unstructured":"Timek A, Daniels-Brady C, Ferrando S. Improvement in depressive symptoms in a patient with severe and enduring anorexia nervosa and comorbid major depressive disorder using psychotherapy-assisted IV ketamine: a case report. J Eat Disord. 2024;12(1):79.","journal-title":"J Eat Disord"},{"key":"1313_CR26","doi-asserted-by":"crossref","unstructured":"Dechant E, Boyle B, Ross A. R. Ketamine in a Patient with Comorbid Anorexia and MDD. J Womens Health Dev [Internet]. 2020 [cited 2025 Jan 12];03(03). Available from: http:\/\/www.fortunejournals.com\/articles\/ketamine-in-a-patient-with-comorbid-anorexia-and-mdd.html","DOI":"10.26502\/fjwhd.2644-28840044"},{"issue":"1","key":"1313_CR27","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1192\/bjo.2021.1061","volume":"8","author":"Z Walsh","year":"2022","unstructured":"Walsh Z, Mollaahmetoglu OM, Rootman J, Golsof S, Keeler J, Marsh B, et al. Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review. BJPsych Open. 2022;8(1):e19.","journal-title":"BJPsych Open"},{"issue":"3","key":"1313_CR28","first-page":"285","volume":"7","author":"V Kotoula","year":"2022","unstructured":"Kotoula V, Stringaris A, Mackes N, Mazibuko N, Hawkins PCT, Furey M, et al. Ketamine modulates the neural correlates of reward processing in unmedicated patients in remission from depression. Biol Psychiatry Cogn Neurosci Neuroimaging. 2022;7(3):285\u201392.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"issue":"6","key":"1313_CR29","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1097\/ALN.0000000000002667","volume":"130","author":"V Sterpenich","year":"2019","unstructured":"Sterpenich V, Vidal S, Hofmeister J, Michalopoulos G, Bancila V, Warrot D, et al. Increased reactivity of the mesolimbic reward system after ketamine injection in patients with Treatment-resistant major depressive disorder. Anesthesiology. 2019;130(6):923\u201335.","journal-title":"Anesthesiology"},{"issue":"1","key":"1313_CR30","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41398-019-0624-1","volume":"9","author":"C Yang","year":"2019","unstructured":"Yang C, Yang J, Luo A, Hashimoto K. Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites. Transl Psychiatry. 2019;9(1):280.","journal-title":"Transl Psychiatry"},{"key":"1313_CR31","doi-asserted-by":"publisher","first-page":"172837","DOI":"10.1016\/j.pbb.2019.172837","volume":"188","author":"S Deyama","year":"2020","unstructured":"Deyama S, Duman RS. Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine. Pharmacol Biochem Behav. 2020;188:172837.","journal-title":"Pharmacol Biochem Behav"},{"key":"1313_CR32","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jclinepi.2017.04.026","volume":"89","author":"DS Riley","year":"2017","unstructured":"Riley DS, Barber MS, Kienle GS, Aronson JK, Von Schoen-Angerer T, Tugwell P, et al. CARE guidelines for case reports: explanation and elaboration document. J Clin Epidemiol. 2017;89:218\u201335.","journal-title":"J Clin Epidemiol"},{"key":"1313_CR33","doi-asserted-by":"publisher","unstructured":"Glue P, Russell B, Medlicott NJ. Influence of formulation and route of administration on ketamine\u2019s safety and tolerability: systematic review. Eur J Clin Pharmacol [Internet]. 2021 May [cited 2025 Apr 21];77(5):671\u20136. Available from: http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s00228-020-03047-z","DOI":"10.1007\/s00228-020-03047-z"},{"issue":"2","key":"1313_CR34","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1177\/02698811241227026","volume":"38","author":"P Glue","year":"2024","unstructured":"Glue P, Neehoff S, Beaglehole B, Shadli S, McNaughton N, Hughes-Medlicott NJ. Ketamine for treatment-resistant major depressive disorder: Double-blind active-controlled crossover study. J Psychopharmacol (Oxf). 2024;38(2):162\u20137.","journal-title":"J Psychopharmacol (Oxf)"},{"key":"1313_CR35","doi-asserted-by":"publisher","unstructured":"Tsang VWL, Tao B, Dames S, Walsh Z, Kryskow P. Safety and tolerability of intramuscular and sublingual ketamine for psychiatric treatment in the Roots To Thrive ketamine-assisted therapy program: a retrospective chart review. Ther Adv Psychopharmacol [Internet]. 2023 Jan [cited 2025 Apr 21];13:20451253231171512. Available from: https:\/\/journals.sagepub.com\/doi\/https:\/\/doi.org\/10.1177\/20451253231171512","DOI":"10.1177\/20451253231171512"},{"issue":"1","key":"1313_CR36","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1186\/s12888-022-04268-5","volume":"22","author":"S Ahuja","year":"2022","unstructured":"Ahuja S, Brendle M, Smart L, Moore C, Thielking P, Robison R. Real-world depression, anxiety and safety outcomes of intramuscular ketamine treatment: a retrospective descriptive cohort study. BMC Psychiatry. 2022;22(1):634.","journal-title":"BMC Psychiatry"},{"issue":"4","key":"1313_CR37","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/1098-108X(199412)16:4<363::AID-EAT2260160405>3.0.CO;2-#","volume":"16","author":"CG Fairburn","year":"1994","unstructured":"Fairburn CG, Beglin SJ. Assessment of eating disorders: interview or self-report questionnaire? Int J Eat Disord. 1994;16(4):363\u201370.","journal-title":"Int J Eat Disord"},{"issue":"5","key":"1313_CR38","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.brat.2008.02.003","volume":"46","author":"JM Mond","year":"2008","unstructured":"Mond JM, Myers TC, Crosby RD, Hay PJ, Rodgers B, Morgan JF, et al. Screening for eating disorders in primary care: EDE-Q versus SCOFF. Behav Res Ther. 2008;46(5):612\u201322.","journal-title":"Behav Res Ther"},{"issue":"6","key":"1313_CR39","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3109\/08039481003797235","volume":"64","author":"O Ro","year":"2010","unstructured":"Ro O, Reas DL, Lask B. Norms for the eating disorder examination questionnaire among female university students in Norway. Nord J Psychiatry. 2010;64(6):428\u201332.","journal-title":"Nord J Psychiatry"},{"issue":"18","key":"1313_CR40","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1001\/jama.282.18.1737","volume":"282","author":"RL Spitzer","year":"1999","unstructured":"Spitzer RL. Validation and utility of a Self-report version of PRIME-MDThe PHQ primary care study. JAMA. 1999;282(18):1737.","journal-title":"JAMA"},{"issue":"9","key":"1313_CR41","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313.","journal-title":"J Gen Intern Med"},{"issue":"1","key":"1313_CR42","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1186\/s12888-022-04101-z","volume":"22","author":"M Brattmyr","year":"2022","unstructured":"Brattmyr M, Lindberg MS, Solem S, Hjemdal O, Havnen A. Factor structure, measurement invariance, and concurrent validity of the patient health Questionnaire-9 and the generalized anxiety disorder scale-7 in a Norwegian psychiatric outpatient sample. BMC Psychiatry. 2022;22(1):461.","journal-title":"BMC Psychiatry"},{"issue":"10","key":"1313_CR43","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JBW, L\u00f6we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092.","journal-title":"Arch Intern Med"},{"issue":"4","key":"1313_CR44","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, \u00c5sberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134(4):382\u20139.","journal-title":"Br J Psychiatry"},{"key":"1313_CR45","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jpsychires.2015.06.003","volume":"68","author":"ED Ballard","year":"2015","unstructured":"Ballard ED, Luckenbaugh DA, Richards EM, Walls TL, Brutsch\u00e9 NE, Ameli R, et al. Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant. J Psychiatr Res. 2015;68:68\u201373.","journal-title":"J Psychiatr Res"},{"issue":"10","key":"1313_CR46","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, Janssen Mf, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727\u201336.","journal-title":"Qual Life Res"},{"issue":"2","key":"1313_CR47","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/BRS.0b013e3181b43bdf","volume":"35","author":"RD Adobor","year":"2010","unstructured":"Adobor RD, Rimesl\u00e5tten S, Keller A, Brox JI. Repeatability, reliability, and concurrent validity of the scoliosis research Society-22 questionnaire and EuroQol in patients with adolescent idiopathic scoliosis. Spine. 2010;35(2):206\u20139.","journal-title":"Spine"},{"issue":"4","key":"1313_CR48","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.beth.2011.03.007","volume":"42","author":"FW Bond","year":"2011","unstructured":"Bond FW, Hayes SC, Baer RA, Carpenter KM, Guenole N, Orcutt HK, et al. Preliminary psychometric properties of the acceptance and action Questionnaire\u2013II: A revised measure of psychological inflexibility and experiential avoidance. Behav Ther. 2011;42(4):676\u201388.","journal-title":"Behav Ther"},{"key":"1313_CR49","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jcbs.2019.12.002","volume":"15","author":"T \u00d8stergaard","year":"2020","unstructured":"\u00d8stergaard T, Lundgren T, Zettle RD, Landr\u00f8 NI, Haaland V\u00d8. Norwegian acceptance and action questionnaire (NAAQ): A psychometric evaluation. J Context Behav Sci. 2020;15:103\u20139.","journal-title":"J Context Behav Sci"},{"key":"1313_CR50","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.jad.2020.01.120","volume":"266","author":"B Short","year":"2020","unstructured":"Short B, Dong V, G\u00e1lvez V, Vulovic V, Martin D, Bayes AJ, et al. Development of the ketamine side effect tool (KSET). J Affect Disord. 2020;266:615\u201320.","journal-title":"J Affect Disord"},{"key":"1313_CR51","doi-asserted-by":"publisher","first-page":"1392135","DOI":"10.3389\/fnut.2024.1392135","volume":"11","author":"GKW Frank","year":"2024","unstructured":"Frank GKW, Scolnick B. Therapeutic ketogenic diet as treatment for anorexia nervosa. Front Nutr. 2024;11:1392135.","journal-title":"Front Nutr"},{"key":"1313_CR52","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.mehy.2017.10.011","volume":"109","author":"B Scolnick","year":"2017","unstructured":"Scolnick B. Ketogenic diet and anorexia nervosa. Med Hypotheses. 2017;109:150\u20132.","journal-title":"Med Hypotheses"},{"issue":"7","key":"1313_CR53","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/qjmed\/91.7.493","volume":"91","author":"I Mills","year":"1998","unstructured":"Mills I. Treatment of compulsive behaviour in eating disorders with intermittent ketamine infusions. QJM. 1998;91(7):493\u2013503.","journal-title":"QJM"},{"issue":"3","key":"1313_CR54","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3390\/brainsci12030382","volume":"12","author":"A Ragnhildstveit","year":"2022","unstructured":"Ragnhildstveit A, Slayton M, Jackson LK, Brendle M, Ahuja S, Holle W, et al. Ketamine as a novel psychopharmacotherapy for eating disorders: evidence and future directions. Brain Sci. 2022;12(3):382.","journal-title":"Brain Sci"},{"key":"1313_CR55","doi-asserted-by":"publisher","first-page":"116334","DOI":"10.1016\/j.psychres.2024.116334","volume":"344","author":"A Bayes","year":"2025","unstructured":"Bayes A, Cao TV, Barreiros AR, Massaneda-Tuneu C, Dong V, Thornton N, et al. Safety outcomes of ketamine for treatment-resistant depression in clinical settings and development of the ketamine side effect tool-revised (KSET-R). Psychiatry Res. 2025;344:116334.","journal-title":"Psychiatry Res"},{"key":"1313_CR56","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3389\/fpsyt.2019.00991","volume":"10","author":"C Gramaglia","year":"2020","unstructured":"Gramaglia C, Gambaro E, Zeppegno P. Alexithymia and treatment outcome in anorexia nervosa: A scoping review of the literature. Front Psychiatry. 2020;10:991.","journal-title":"Front Psychiatry"},{"key":"1313_CR57","doi-asserted-by":"publisher","first-page":"916641","DOI":"10.3389\/fphar.2022.916641","volume":"13","author":"K Stocker","year":"2022","unstructured":"Stocker K, Hartmann M, Reissmann S, Kist A, Liechti ME. Buddhist-like opposite diminishing and non-judging during ketamine infusion are associated with antidepressant response: an open-label personalized-dosing study. Front Pharmacol. 2022;13:916641.","journal-title":"Front Pharmacol"},{"issue":"2","key":"1313_CR58","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1556\/2054.2022.00199","volume":"6","author":"A Ka\u0142u\u017cna","year":"2022","unstructured":"Ka\u0142u\u017cna A, Schlosser M, Gulliksen Craste E, Stroud J, Cooke J. Being no one, being one: the role of ego-dissolution and connectedness in the therapeutic effects of psychedelic experience. J Psychedelic Stud. 2022;6(2):111\u201336.","journal-title":"J Psychedelic Stud"},{"key":"1313_CR59","doi-asserted-by":"publisher","first-page":"695335","DOI":"10.3389\/fpsyt.2021.695335","volume":"12","author":"OM Mollaahmetoglu","year":"2021","unstructured":"Mollaahmetoglu OM, Keeler J, Ashbullby KJ, Ketzitzidou-Argyri E, Grabski M, Morgan CJA. This is something that changed my life: A qualitative study of patients\u2019 experiences in a clinical trial of ketamine treatment for alcohol use disorders. Front Psychiatry. 2021;12:695335.","journal-title":"Front Psychiatry"},{"issue":"1","key":"1313_CR60","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41386-023-01629-w","volume":"49","author":"JH Krystal","year":"2024","unstructured":"Krystal JH, Kavalali ET, Monteggia LM. Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms. Neuropsychopharmacology. 2024;49(1):41\u201350.","journal-title":"Neuropsychopharmacology"},{"key":"1313_CR61","doi-asserted-by":"crossref","unstructured":"Agnorelli C, Spriggs M, Godfrey K, Sawicka G, Bohl B, Douglass H et al. Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models. Neurosci Biobehav Rev [Internet]. 2025 May [cited 2025 Apr 21];172:106132. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763425001320","DOI":"10.1016\/j.neubiorev.2025.106132"}],"container-title":["Journal of Eating Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40337-025-01313-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40337-025-01313-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40337-025-01313-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T11:02:56Z","timestamp":1749553376000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeatdisord.biomedcentral.com\/articles\/10.1186\/s40337-025-01313-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1313"],"URL":"https:\/\/doi.org\/10.1186\/s40337-025-01313-y","relation":{},"ISSN":["2050-2974"],"issn-type":[{"value":"2050-2974","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"assertion":[{"value":"16 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient, who agreed to share her data for the current case report. The patient was informed that she was free to contact the clinic\u2019s medical director or the clinical psychologist who had treated her at any point in time during the publication process, or after the article is published, should she have any questions or concerns regarding her participation. The Regional Committees for Medical and Health Research Ethics (REK) South-East (reference ID 806316) and Sikt -the Norwegian Agency for Shared Services in Education and Research (reference ID 665591) approved the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient was informed that she could withdraw her consent at any time leading up to the publication of the article, but not after the article had been published online.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}